Chinese expert consensus on off-label drug list (Pediatrics 2024 version)

Title: Chinese expert consensus on off-label drug list (Pediatrics 2024 version)
Edition: Updated
Classification: Experts consensus
Field: Treatment
Countries and regions: China
Guidelines users: 医生、护士、药师
Evidence classification method: The Thomson classification system standard of Micromedex and reference to other authoritative guidelines and consensus grading standards
Development unit: Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University、Shenzhen Children's Hospital、Hospital Pharmacy Committee of Guangdong Pharmaceutical Society、 Pediatric Clinical Rational Drug Use Expert Committee of Guangdong Pharmaceutical Society
Registration time: 2024-09-03
Registration number: PREPARE-2024CN389
Purpose of the guideline: The management of pediatric off-label drug use is an important issue faced by all hospitals. In order to assist all medical institutions to develop the catalog of pediatric off-label drug use for reference of all medical institutions.